Bristol Myers Squibb’s highly…
Bristol Myers Squibb’s highly anticipated Cobenfy just finished its first [...]
Bristol Myers Squibb’s highly anticipated Cobenfy just finished its first [...]
Despite the largest U.S. pharmacy benefit manager knocking Zepbound off [...]
The agency announced moves to cut regulatory obstacles for the [...]
The FDA has revealed a set of measures designed to [...]
After a progression-free survival win last year raised hopes for [...]
The lawsuit follows claims by President Trump that linked use [...]
No existe ningún producto de testosterona para mujeres aprobado por [...]
The drug, one of the few nonhormonal options for menopausal [...]
Following a slight delay earlier this year—and a world-first green [...]
Ipsen unveiled a new educational initiative dedicated to supporting teenagers [...]